Canada Royal Enoch Phytomedicine Ltd.
Our headquarter is located in Vancouver, Canada. We are a hi-tech enterprise group mainly engaged in research,
production and sales of natural plant-based products. We aim to extract active ingredients from natural herbal plants.
Developmental Timeline
  • 2005

    Began to produce highly-purified rare ginsenosides Rg3, Rh2, Rh1, aPPD and aPPT etc., in large scale, at the same time, successfully developed natural plant skin care products with anti-oxidant, anti-aging, and skin-tone-evening properties. These products were sold in beauty salons.
  • 2009

    Developed “the rare ginsenosideaglycone protopanaxadiol (aPPD) micro packaging soft gelatin capsules”.
  • 2010

    Achieved a break-through in our proprietary technology “production of the highly purified aglycone protopanaxadiol (aPPD) and the aglycone proto-
    panaxatriol (aPPT) by oxidation catalysis”.
  • 2011

    Developed an industrialized production technology in transforming protopanaxadiol to rare ginsenosides Rk1, Rg5, Rk2, Rh3, at the same
    time, successfully developed water-soluble and lipid-soluble gelatin capsules.
  • 2012

    North American and European users began to take the Redsenol-1 Noble Ginsenosides capsules.
  • 2013-2015

    Tested rare ginsenosides' effects through in vitro cell experiments, and obtained confirming results on their broad-spectrum activity.
  • 2016

    Worked on market promotion of the Redsenol-1 Noble Ginsenosides capsules.
  • 2017

    Meticulously selected eight highly active rare ginsneosides for the preparation-----Redsenol-DAG sublingual pills.
Future Directions
We look to convert rare ginsenosides and their analogs to more active pharmaceutical molecules through structure-based drug design. We aim to keep our technological superiority in industrialized production of rare ginsenosides, while developing new preparation technology. We believe that with improved drug bioavailability and drug production costs, more users will eventually be benefited.
Enterprise Culture
A Great Scientific Achievement
Canada Royal Enoch Phytomedicine Ltd. selects the highest quality Araliaceae ginseng species on a global scale (Asian ginseng, American ginseng, panax notoginseng, etc.), at the same time, extracts and separates various ginsenosides from the root of the ginseng plants. These ginsenosides are transformed into 16 active rare ginsenosides (analogs) (Rk2, Rg3, Rh2, Rg5, Rk1, Rk3, Rh1, Rh3, Rh4, aPPT, aPPD) in industrialized settings, and are further processed into making the Redsenol Rare Ginsenosides capsule. With further research, they meticulously select 8 highly active rare ginsenosides to formulate Redsenol-DAG sublingual pills. Redsenol meets U.S. Pharmacopeial Convention (USP), each capsule has gone through 70 strict screenings by Labs-Mart Inc. located in Canada (i.e. 5 heavy metal contaminants screenings, 5 microbial contaminants screenings, 60 pesticide residue screenings). Redsenol Rare Ginsenosides capsule is confirmed to be safe and effective, suitable for long-term use.
R&D Milestones
Phase 1:
2005—2010
-
The R&D team conquered technical barriers in bulk production of the rare ginsenosides Rg3,Rh2,Rh1, aPPD,aPPT,etc.,in industrialized settings.
Phase 2:
2010—2012
-
The R&D team conquered technical barriers in industrialized production of the more hard-to-obtain rare ginsenosides Rk1, Rk2, Rh3, Rg5, etc. We are now the first institution in the world possessing such technology.
Phase 3:
2012—2014
-
The R&D team conducted plenty of research into rare ginsenosides Rk1,Rk2,Rh3,Rg5,etc., and the results confirmed their roles in enhancing human health.
Standard Production Process
Standard Manufacturing Workshop
Dan Deng
Chemical engineer
-
Canada Royal Enoch Phytomedicine Ltd. chief chemical engineer
Martin Wang
Ph.D. in Chinese medicine
-
Ph.D. in Chinese medicine, Nanjing University of Chinese Medicine Post-doctoral fellow, Toyama Medical and Pharmaceutical University and Chinese Medicine Research Institute
Muyuan (Sophie) Zhong
Msc in Pharmacology and Biomedical Toxicology
-
Msc in Pharmacology and Biomedical Toxicology, University of Toronto.Core member of the R & D team
3800 Wesbrook Mall Vancouver,
BC Canada,V6S 2L9
604-638-9936
global@enophyto.com
redsenolhealth
Copyright © 2016, Canada Royal Enoch Phytomedicine LTD. All rights reserved.